MyMD Pharmaceuticals was issued a patent by the United States Patent & Trademark Office (USPTO) for Supera-CBD, a preclinical cannabidiol derivative for substance addiction and other disorders

View More

Back to All News

  • This field is for validation purposes and should be left unchanged.